Transforming treatment decisions with clinically actionable insights
Now approved for patients in all 50 states, including New York — The Oncology Hotspot assay detects actionable variants in advanced solid tumor cancer to help clinicians personalize and optimize cancer therapy.
Highly SensitiveThe power to detect variants down to 5% allele fraction.
ActionableIdentifies clinically-actionable variants in 50 genes to help optimize treatment planning.
PreciseAnalyzes specific variants within 207 regions of the genome known to be associated with cancer diagnosis, prognosis, and treatment response.